Based on CAGR alone, SPHQ is a Strong Buy. It also outperforms the S&P 500 (13.69% v. 11.16%) and fully participates in up ...

Vanguard Growth ETF (VUG) is rated Buy. Its robust tech earnings and AI trends drive growth into 2026. Read here for a ...

The Supreme Court of Ghana has unanimously ruled that Alpha Beta Education Centre Limited holds valid title to parcels of ...

Detailed price information for Agios Pharmaceuticals (AGIO-Q) from The Globe and Mail including charting and trades.

The Supreme Court has unanimously ruled that Alpha Beta Education Centres Limited holds a valid title to parcels of land at Dansoman–Akokorfoto in Accra, bringing to a close a land dispute that began ...

The approval makes AQVESME the only FDA-approved medicine for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, a rare blood disorder. The drug is expected ...

Agios Pharmaceuticals wins FDA approval for Aqvesme in alpha- and beta-thalassemia, making mitapivat the only approved option, despite a new REMS.

Tavistock Investments ( ($GB:TAVI) ) just unveiled an update. Tavistock Investments reported a 23% rise in gross revenues to £11.1m from ongoing ...

Past returns often dominate mutual fund discussions, but they don’t tell the full story. Understanding risk, consistency and ...

Detailed price information for American Tower Corp (AMT-N) from The Globe and Mail including charting and trades.

Discover essential metrics like alpha, beta, and Sharpe ratio for evaluating mutual fund risk-return tradeoffs. Learn how to assess potential returns and risks effectively.